Shanghai Henlius CEO Wants To Capitalize On First-Mover Status
Scott Liu Sets Out Ambitions That Go Beyond China
• By David Wallace
Shanghai Henlius CEO Dr. Scott Liu says the leading Chinese biologics player will seek to capitalize on its first-mover status • Source: Shanghai Henlius Biotech
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
